Redpoint Bio Corporation Researchers Develop Method of Measuring and Classifying Bitterness in a Broad Range of Orally Aversive Pharmaceuticals

EWING, N.J.--(BUSINESS WIRE)--Scientists at Redpoint Bio Corporation (OTCBB: RPBC) have developed a quantitative method to measure and classify the bitter or bad taste of frequently used medicines. The work points to approaches that have the potential to reduce or eliminate the aversive flavor of many widely prescribed orally-dosed drugs. The findings appear in the October 2008 issue of the peer-reviewed journal Behavioural Pharmacology.
MORE ON THIS TOPIC